Business · 06/09/2018
FDA Releases Guidance for Developing Drug Products for Nonallergic Rhinitis Treatment
The Food and Drug Administration has made available a guidance document to help pharmaceutical companies develop new treatments for nonallergic rhinitis in children and adults, building on comments received since its initial release in February 2016.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →